Compositions and methods for immunooncology
US11851659B2 · kind B2 · utility
0Cited by
62References
44Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 21, 2018 |
| Grant date | Dec 26, 2023 |
| Priority date | — |
| Expiry date | Nov 20, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure is directed to genome editing systems, reagents and methods for immunooncology.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.